Buy Detralex tablets 500mg; 1000mg online. Free worldwide shipping.
Brand: Les Laboratoires Servier (France)
Drug form: Tablet
Manufacturers: Les Laboratoires Servier Industrie (Франция)
Active substance: Purified, micronized flavonoid fraction
Group: Venotonic and venoprotective agent
Expiration date:
We accept payments through Paypal which guarantees our customers the protection of theirs funds in case of any possible delivery issues.
We undertake all fees for the delivery and currency exchange. Read more about customer protection:
https://www.paypal.com/us/webapps/mpp/paypal-safety-and-security
Feel free to contact us in case of any questions: manager@befitpharma.com
DETRALEX tablets 500mg; 1000mg
Indications for use of Detralex are:
Detralex® is indicated for the treatment of symptoms of chronic venous diseases (elimination and relief of symptoms).
Therapy for symptoms of venous lymphatic insufficiency:
- pain;
- cramps of the lower extremities;
- a feeling of heaviness and fullness in the legs;
- "tiredness" of the legs.
Therapy of manifestations of venous-lymphatic insufficiency:
- edema of the lower extremities;
- trophic changes in the skin and subcutaneous tissue;
- venous trophic ulcers.
Symptomatic therapy for acute and chronic hemorrhoids.
Pharmachologic effect
Detralex has venotonic and angioprotective properties. The drug reduces the elasticity of veins and venous stasis, reduces capillary permeability and increases their resistance. The results of clinical studies confirm the pharmacological activity of the drug in relation to the parameters of venous hemodynamics.
The statistically significant dose-dependent effect of Detralex was demonstrated for the following venous plethysmographic parameters: venous capacity, venous extensibility, and venous emptying time.
The optimal dose-response ratio is observed at a dose of 1000 mg per day.
Detralex increases venous tone: with the help of venous occlusive plethysmography, a decrease in the time of venous emptying has been shown. In patients with signs of severe microcirculation disorders, after therapy with Detralex, an increase in capillary resistance, assessed by the method of angiostereometry, is noted (statistically significant, compared with placebo).
The therapeutic efficacy of Detralex has been proven in the treatment of chronic diseases of the veins of the lower extremities, as well as in the treatment of hemorrhoids.
1 tablet contains a purified micronized flavonoid fraction 1, including: diosmin (90%) flavonoids in terms of hesperidin (10%)